Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Kiromic BioPharma Inc. KRBP

Kiromic BioPharma Inc is a biotechnology company. The company is a gene-editing which utilizes artificial intelligence and a proprietary neural network platform with a therapeutic focus on immuno-oncology.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:KRBP)

Fundamentals Snapshot (NDAQ:KRBP)

Current News (NDAQ:KRBP)

SHAREHOLDER ALERT: Kiromic Biopharma, Inc. (KRBP) Officers and Directors Under Investigation for Possible False Statements About Its Commercial Prospects

PR Newswire November 8, 2022

Kiromic BioPharma Arranges Up to $10 Million Financing

Business Wire October 27, 2022

Kiromic BioPharma Announces FDA Feedback from Type B Pre-IND Meeting Confirms Deltacel Development Strategy

Business Wire October 6, 2022

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 4, 2022 in Kiromic Lawsuit - KRBP

Newsfile October 4, 2022

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Kiromic BioPharma (KRBP) Investors with Losses to Lead Plaintiff Deadline in Securities Class Action

Newsfile October 4, 2022

FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the Firm

PR Newswire October 4, 2022

Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Kiromic BioPharma, Inc. (KRBP) Investors of Class Action and to Actively Participate

Newsfile October 4, 2022

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the Firm

Newsfile October 4, 2022

KRBP ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 4, 2022 in the Class Action Filed on Behalf of Kiromic BioPharma, Inc. Shareholders

PR Newswire October 4, 2022

Opinion & Analysis (NDAQ:KRBP)

No current opinion is available.

Bullboard Posts (NDAQ:KRBP)

KRBP ..... told ya ; )

Now the next time your out....make sure you take some time to donate to a charitable organization.  You're welcome
Iseneschal - October 6, 2022

KRBP ....early a.m runner on watch

Has to hold ~ $0.48 or it's going to PB hard.....history tells me ; )  Cheers!
Iseneschal - October 6, 2022